Grant opportunity preview

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Offered by National Institutes of Health

HealthcareNationalNovember 10, 2026

Opportunity summary

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved…

Sign in to review full eligibility requirements, application details, matching insights, and verified source links.

Potential award

$150,000

A free Grantclient account is required.